199 related articles for article (PubMed ID: 22266469)
1. Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes.
St John AL; Chan CY; Staats HF; Leong KW; Abraham SN
Nat Mater; 2012 Jan; 11(3):250-7. PubMed ID: 22266469
[TBL] [Abstract][Full Text] [Related]
2. Unimpaired Responses to Vaccination With Protein Antigen Plus Adjuvant in Mice With Kit-Independent Mast Cell Deficiency.
Schubert N; Lisenko K; Auerbach C; Weitzmann A; Ghouse SM; Muhandes L; Haase C; Häring T; Schulze L; Voehringer D; Gunzer F; Müller W; Feyerabend TB; Rodewald HR; Dudeck A; Roers A
Front Immunol; 2018; 9():1870. PubMed ID: 30210490
[TBL] [Abstract][Full Text] [Related]
3. Vaccine adjuvants: Tailor-made mast-cell granules.
Gunzer M
Nat Mater; 2012 Feb; 11(3):181-2. PubMed ID: 22349854
[No Abstract] [Full Text] [Related]
4. Adjuvants may reduce in vivo transfection levels for DNA vaccination in mice leading to reduced antigen-specific CD8+ T cell responses.
Rose AH; Hoffmann FW; Hara JH; Urschitz J; Moisyadi S; Hoffmann PR; Bertino P
Hum Vaccin Immunother; 2015; 11(9):2305-11. PubMed ID: 26091088
[TBL] [Abstract][Full Text] [Related]
5. Tumor ablation plus co-administration of CpG and saponin adjuvants affects IL-1 production and multifunctional T cell numbers in tumor draining lymph nodes.
Raaijmakers TK; van den Bijgaart RJE; den Brok MH; Wassink M; de Graaf A; Wagenaars JA; Nierkens S; Ansems M; Scheffer GJ; Adema GJ
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461350
[TBL] [Abstract][Full Text] [Related]
6. Mast cell-derived particles deliver peripheral signals to remote lymph nodes.
Kunder CA; St John AL; Li G; Leong KW; Berwin B; Staats HF; Abraham SN
J Exp Med; 2009 Oct; 206(11):2455-67. PubMed ID: 19808250
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.
Kayamuro H; Yoshioka Y; Abe Y; Arita S; Katayama K; Nomura T; Yoshikawa T; Kubota-Koketsu R; Ikuta K; Okamoto S; Mori Y; Kunisawa J; Kiyono H; Itoh N; Nagano K; Kamada H; Tsutsumi Y; Tsunoda S
J Virol; 2010 Dec; 84(24):12703-12. PubMed ID: 20881038
[TBL] [Abstract][Full Text] [Related]
8. MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action.
Caproni E; Tritto E; Cortese M; Muzzi A; Mosca F; Monaci E; Baudner B; Seubert A; De Gregorio E
J Immunol; 2012 Apr; 188(7):3088-98. PubMed ID: 22351935
[TBL] [Abstract][Full Text] [Related]
9. Mast cells and γδ T cells are largely dispensable for adaptive immune responses after laser-mediated epicutaneous immunization.
Joubert IA; Kovacs D; Scheiblhofer S; Winter P; Korotchenko E; Strandt H; Weiss R
Vaccine; 2020 Jan; 38(5):1015-1024. PubMed ID: 31812465
[TBL] [Abstract][Full Text] [Related]
10. Mast cell-orchestrated immunity to pathogens.
Abraham SN; St John AL
Nat Rev Immunol; 2010 Jun; 10(6):440-52. PubMed ID: 20498670
[TBL] [Abstract][Full Text] [Related]
11. Mast cell activation and migration to lymph nodes during induction of an immune response in mice.
Wang HW; Tedla N; Lloyd AR; Wakefield D; McNeil PH
J Clin Invest; 1998 Oct; 102(8):1617-26. PubMed ID: 9788976
[TBL] [Abstract][Full Text] [Related]
12. Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice.
Heib V; Becker M; Warger T; Rechtsteiner G; Tertilt C; Klein M; Bopp T; Taube C; Schild H; Schmitt E; Stassen M
Blood; 2007 Aug; 110(3):946-53. PubMed ID: 17446350
[TBL] [Abstract][Full Text] [Related]
13. Engulfment of mast cell secretory granules on skin inflammation boosts dendritic cell migration and priming efficiency.
Dudeck J; Froebel J; Kotrba J; Lehmann CHK; Dudziak D; Speier S; Nedospasov SA; Schraven B; Dudeck A
J Allergy Clin Immunol; 2019 May; 143(5):1849-1864.e4. PubMed ID: 30339853
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
[TBL] [Abstract][Full Text] [Related]
15. The allergy adjuvant effect of particles - genetic factors influence antibody and cytokine responses.
Nygaard UC; Aase A; Løvik M
BMC Immunol; 2005 Jun; 6():11. PubMed ID: 15967044
[TBL] [Abstract][Full Text] [Related]
16. Mast cells recruited to mesenteric lymph nodes during helminth infection remain hypogranular and produce IL-4 and IL-6.
Liu AY; Dwyer DF; Jones TG; Bankova LG; Shen S; Katz HR; Austen KF; Gurish MF
J Immunol; 2013 Feb; 190(4):1758-66. PubMed ID: 23319739
[TBL] [Abstract][Full Text] [Related]
17. Mast cell activators: a new class of highly effective vaccine adjuvants.
McLachlan JB; Shelburne CP; Hart JP; Pizzo SV; Goyal R; Brooking-Dixon R; Staats HF; Abraham SN
Nat Med; 2008 May; 14(5):536-41. PubMed ID: 18425129
[TBL] [Abstract][Full Text] [Related]
18. Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles.
Tonkin DR; Whitmore A; Johnston RE; Barro M
Vaccine; 2012 Jun; 30(30):4532-42. PubMed ID: 22531556
[TBL] [Abstract][Full Text] [Related]
19. A short hairpin RNA-based adjuvant targeting NF-κB repressor IκBα promotes migration of dermal dendritic cells to draining lymph nodes and antitumor CTL responses induced by DNA vaccination.
Gálvez-Cancino F; Roco J; Rojas-Colonelli N; Flores C; Murgas P; Cruz-Gómez S; Oyarce C; Varas-Godoy M; Sauma D; Lladser A
Vaccine; 2017 Jul; 35(33):4148-4154. PubMed ID: 28666759
[TBL] [Abstract][Full Text] [Related]
20. Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
Seydoux E; Liang H; Dubois Cauwelaert N; Archer M; Rintala ND; Kramer R; Carter D; Fox CB; Orr MT
J Immunol; 2018 Jul; 201(1):98-112. PubMed ID: 29769270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
